Etoposide Catechol Is an Oxidizable Topoisomerase II Poison

被引:18
|
作者
Jacob, David A. [1 ]
Gibson, Elizabeth G. [1 ]
Mercer, Susan L. [1 ,2 ]
Deweese, Joseph E. [1 ,3 ]
机构
[1] Lipscomb Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Nashville, TN 37204 USA
[2] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
关键词
O-DEMETHYLATION; DNA CLEAVAGE; QUINONE; METABOLITES; LEUKEMIA; ALPHA;
D O I
10.1021/tx400205n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Topoisomerase II regulates DNA topology by generating transient double-stranded breaks. The anticancer drug etoposide targets topoisomerase II and is associated with the formation of secondary leukemias in patients. The quinone and catechol metabolites of etoposide may contribute to strand breaks that trigger leukemic translocations. To further analyze the characteristics of etoposide metabolites, we extend our previous analysis of etoposide quinone to the catechol. We demonstrate that the catechol is similar to 2-3-fold more potent than etoposide and under oxidative reaction conditions induces high levels of double-stranded DNA cleavage. These results support a role for etoposide catechol in contributing to therapy-induced DNA damage.
引用
收藏
页码:1156 / 1158
页数:3
相关论文
共 50 条
  • [41] The mycotoxin alternariol acts as a topoisomerase poison, preferentially affecting the II α isoform
    Fehr, M.
    Pahlke, G.
    Fritz, J.
    Christensen, M. O.
    Boege, F.
    Altemoeller, M.
    Podlech, J.
    Marko, D.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 79 - 79
  • [42] Sequential topotecan (topoisomerase I inhibitor) and etoposide (topoisomerase II inhibitor) in advanced, adult solid tumours
    Watson, JV
    Bulusu, VR
    Deary, A
    BRITISH JOURNAL OF CANCER, 1998, 78 : 34 - 34
  • [43] Inhibition of Mycobacterium tuberculosis topoisomerase I by m-AMSA, a eukaryotic type II topoisomerase poison
    Godbole, Adwait Anand
    Ahmed, Wareed
    Bhat, Rajeshwari Subray
    Bradley, Erin K.
    Ekins, Sean
    Nagaraja, Valakunja
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 446 (04) : 916 - 920
  • [44] Etoposide promotes DNA loop trapping and barrier formation by topoisomerase II
    Le, Tung T.
    Wu, Meiling
    Lee, Joyce H.
    Bhatt, Neti
    Inman, James T.
    Berger, James M.
    Wang, Michelle D.
    NATURE CHEMICAL BIOLOGY, 2023, 19 (05) : 641 - +
  • [45] TOPOISOMERASE II IS OVEREXPRESSED IN GLIOBLASTOMA AND IS A POTENTIALLY USEFUL PREDICTOR OF ETOPOSIDE SENSITIVITY
    Parkinson, Jonathon
    Shaw, Janet
    Payne, Cathy
    Brewer, Janice
    Wheeler, Helen
    Cook, Raymond
    Biggs, Michael
    Little, Nicholas
    Teo, Charles
    Messina, Marinella
    Rohinson, Bruce
    Mcdonald, Kerrie
    NEURO-ONCOLOGY, 2008, 10 (05) : 863 - 863
  • [46] A diazirine-based photoaffinity etoposide probe for labeling topoisomerase II
    Chee, Gaik-Lean
    Yalowich, Jack C.
    Bodner, Andrew
    Wu, Xing
    Hasinoff, Brian B.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (02) : 830 - 838
  • [47] Effects of benzene metabolites on DNA cleavage mediated by human topoisomerase IIα:: 1,4-hydroquinone is a topoisomerase II poison
    Lindsey, RH
    Bender, RP
    Osheroff, N
    CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (04) : 761 - 770
  • [48] Etoposide catechol, is it an important metabolite?
    Ghazaly, Essam
    Joel, Simon
    Johnston, Atholl
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (06) : 984 - 985
  • [49] Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan
    PerezSoler, R
    Glisson, BS
    Lee, JS
    Fossella, FV
    Murphy, WK
    Shin, DM
    Hong, WK
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) : 2785 - 2790
  • [50] Alternariol acts as a topoisomerase poison
    Marko, Doris
    Pahlke, Gudrun
    Fehr, Markus
    TOXICOLOGY LETTERS, 2007, 172 : S50 - S50